New Hampshire Code of Administrative Rules
He - Department of Health and Human Services
Subtitle He-P - Former Division of Public Health Services
Chapter He-P 1600 - LEAD POISONING PREVENTION AND CONTROL
Part He-P 1609 - STANDARDS FOR LEAD ABATEMENT
Section He-P 1609.03 - Encapsulant Products and Their Use
Current through Register No. 40, October 3, 2024
(a) Encapsulant products shall be approved in accordance with RSA 130-A:1, VII, or (q) and (r) below prior to their use.
(b) Except for a licensed lead abatement supervisor, lead abatement worker, or owner-contractor, any person who wishes to use an encapsulant product shall request permission from the department by completing and submitting to the department a "Request for Use of Encapsulant Paint", form (May 2020) prior to initiating the work or activity certifying the following:
"I certify that I have read, understand, and agree to comply with the New Hampshire Lead Poisoning Prevention Rules (He-P 1600) and the Lead Poisoning Prevention Statute (RSA 130-A). I agree to follow all rules in He-P 1600 regarding encapsulant products and their use as well as any manufacturer recommendations. I further certify that all information contained herein, including any supplements attached, is true and correct to the best of my knowledge and belief."; and
"I understand that any violation of the law will result in this approval being revoked and could result in administrative fines."
(c) The following shall be submitted with the "Request for Use of Encapsulant Paint" form:
(d) Encapsulant products shall be applied:
(e) Encapsulant products shall not be used on any surface(s) that:
(f) Surface preparation as described in (d)(2) above shall include:
(g) All encapsulant debris generated through the application process and any unused encapsulant not suitable for application shall be disposed of in accordance with the encapsulant manufacturer's instructions.
(h) When encapsulant products have been used and the dwelling, dwelling unit, or child care facility has no documentation of passing the substrate assessment or the substrate assessment test has been failed for any architectural system, element, or building component, the risk assessor shall not issue a certificate of lead hazard control - abatement.
(i) The owner shall perform a visual inspection of the encapsulated surfaces as recommended by the manufacturer and as follows:
(j) The visual inspection required by (i) above shall determine whether the encapsulant has maintained its integrity and is not:
(k) If signs of wear or deterioration, as described in (i) above, are found during the visual inspection, the owner shall visually inspect the encapsulated surfaces at least every 3 months for the next 6 months, then annually thereafter.
(l) If the encapsulation fails to maintain its integrity or if repairs are needed and the affected area involves less than 6 square feet of surface, the repair shall be considered in-place management and shall be remedied in accordance with the encapsulant manufacturer's recommendations, He-P 1608, and He-P 1610.02 through He-P 1610.05.
(m) When repairing a surface as described in (k) above, the owner or owner's agent shall not engage in any practice prohibited under He-P 1609.02(c).
(n) When a repair of the affected area involves more than 6 square feet of surface area, the owner or owner's agent shall remedy the affected area in accordance with lead hazard reductions pursuant to He-P 1608 and as it applies to abatement pursuant to He-P 1609 or interim controls pursuant to He-P 1610, including the requirement for a clearance inspection with dust wipes for the area where work occurred.
(o) In addition to the record keeping requirements of He-P 1608.15, the owner shall maintain the following records for the life of the encapsulant product:
(p) The owner shall make all records required by (o) above available to:
(q) The commissioner shall approve encapsulant products for lead hazard reduction work that have been tested and meet or exceed:
(r) Manufacturers shall submit the following documentation to the commissioner prior to the encapsulation product being approved:
#5920, eff 1-1-95; ss by #7181, eff 12-24-99; ss by #7495, eff 5-23-01; ss by #8039, eff 2-13-04; ss by #8932, eff 7-6-07; ss by #9986, eff 9-1-11 (from He-P 1605.09)